Advertisement

Sputnik V can be highly effective against new COVID-19 strain: Vaccine codeveloper

Follow The Hawk on Google News+ Follow

Advertisement


Moscow: Sputnik V, the world's first COVID-19 vaccine, will be "highly effective" against the new strain of coronavirus found in Europe, said Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund, the company which codeveloped the vaccine.

"According to our information, Sputnik V will be as highly effective against the new strain of the coronavirus found in Europe as against the existing strains. Sputnik V has been showing its efficacy over a period of time despite the previous mutations of S-protein," he said, according to Sputnik V's Twitter handle.

Advertisement

Dmitriev added that it would jointly work with AstraZeneca, another vaccine manufacturing company, to combat the new mutation strain of the COVID-19.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

"Joint work with such a pharmaceutical giant as AstraZeneca is becoming particularly important today, in light of combating the new mutating strains of the coronavirus," he said

The RDIF CEO also said that the Sputnik V has been registered for use in Belarus.

Advertisement

Last week, Russian President Vladimir Putin said that Sputnik V is over 95 per cent effective.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

Taking to Twitter, Russia's Ministry of Foreign Affairs (MFA) cited Putin saying that some health specialists have claimed that the vaccine's protection level reaches up to 96-97 per cent.

Russia became the first country to register the world's first COVID-19 vaccine on August 11, named after Russia's first satellite.

—ANI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST